×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Angina Market Trends

ID: MRFR/Pharma/4293-HCR
90 Pages
Rahul Gotadki
October 2025

Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Angina Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Angina Market

The angina market is encountering growth because of the rising pervasiveness of angina pectoris universally. Factors, for example, maturing populations, rising frequency of cardiovascular risk factors like hypertension and diabetes, and objectionable lifestyle propensities add to the rising predominance of angina, driving interest for indicative and treatment choices. Risk explanation assumes a critical part in directing treatment choices and improving results for patients with angina. Medical services suppliers use risk appraisal devices and scoring frameworks, to separate patients in view of their cardiovascular risk profile, directing customized therapy techniques custom-made to individual patient requirements and chance levels. There is a developing pattern towards harmless treatment choices for angina, focused on side effect help and working on personal satisfaction for patients. Harmless medicines like lifestyle alterations, pharmacological treatments, and heart recovery programs offer powerful management techniques for angina while limiting the requirement for intrusive methodology or medical procedures, upgrading patient solace and adherence to therapy plans. Pharmacological treatments assume a focal part in the management of angina, planning to lessen myocardial ischemia, reduce side effects, and further develop practice resistance in patients. Progresses in pharmacological treatments incorporate the advancement of new antianginal drugs, for example, calcium channel blockers, beta-blockers, nitrates, and ranolazine, offering extra treatment choices and further developed viability for patients with angina. Lifestyle changes are fundamental parts of angina management, focusing in on risk factor alteration and auxiliary avoidance procedures. Medical services suppliers underline the significance of lifestyle mediations like smoking cessation, dietary changes, normal activity, weight management, and stress decrease procedures in lessening cardiovascular risk and further developing results for patients with angina. The reception of telemedicine stages and distant conferences is expanding in the management of angina, giving helpful admittance to cardiovascular consideration for patients with angina. Teleconsultations empower patients to talk with cardiologists from a distance, examine side effects, get treatment proposals, and go through remote observing of their condition, further developing admittance to mind and patient fulfillment.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the current valuation of The Global Angina as of 2024?

The Global Angina was valued at 0.5487 USD Billion in 2024.

What is the projected market valuation for The Global Angina in 2035?

The market is projected to reach a valuation of 0.9909 USD Billion by 2035.

What is the expected CAGR for The Global Angina during the forecast period 2025 - 2035?

The expected CAGR for The Global Angina during the forecast period 2025 - 2035 is 5.52%.

Which companies are considered key players in The Global Angina?

Key players in the market include AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer, Sanofi, Merck & Co., GlaxoSmithKline, Amgen, and Bayer.

What are the main segments of The Global Angina?

The main segments of the market include Type, Diagnosis, Treatment, and End-User.

Market Summary

As per MRFR analysis, The Global Angina Market Size was estimated at 0.5487 USD Billion in 2024. The Angina industry is projected to grow from 0.579 USD Billion in 2025 to 0.9909 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.52 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Global Angina Market is poised for substantial growth driven by technological advancements and demographic shifts.

  • North America remains the largest market for angina treatments, reflecting a robust healthcare infrastructure. The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare investments and awareness. Angina Market Pectoris continues to dominate the market, while Unstable Angina Market is witnessing rapid growth due to evolving treatment protocols. Rising prevalence of cardiovascular diseases and advancements in medical technology are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 0.5487 (USD Billion)
2035 Market Size 0.9909 (USD Billion)
CAGR (2025 - 2035) 5.52%
Largest Regional Market Share in 2024 America

Major Players

<p>AstraZeneca (GB), Bristol-Myers Squibb (US), Novartis (CH), Pfizer (US), Sanofi (FR), <a href="https://www.msdmanuals.com/home/heart-and-blood-vessel-disorders/coronary-artery-disease/angina">Merck &amp; Co.</a> (US), GlaxoSmithKline (GB), Amgen (US), Bayer (DE)</p>

Market Trends

The Global Angina Market is currently experiencing a dynamic evolution, driven by a confluence of factors including advancements in medical technology, an increasing prevalence of cardiovascular diseases, and a growing awareness of heart health among the population. As healthcare systems worldwide adapt to the rising demand for effective angina management solutions, pharmaceutical companies are focusing on innovative therapies and treatment options. This shift is likely to enhance patient outcomes and improve quality of life for individuals suffering from angina. Furthermore, the integration of digital health solutions, such as telemedicine and mobile health applications, appears to be reshaping the landscape of patient care, providing more accessible and personalized treatment pathways. In addition to technological advancements, The Global Angina Market is influenced by demographic changes, particularly the aging population, which tends to exhibit higher rates of cardiovascular conditions. This demographic shift may lead to an increased demand for specialized care and tailored treatment regimens. Moreover, the emphasis on preventive healthcare and lifestyle modifications is gaining traction, suggesting that educational initiatives and community programs could play a pivotal role in managing angina. Overall, the market seems poised for growth, with a focus on innovative therapies, patient-centered care, and preventive strategies that may redefine the approach to angina management.

Technological Advancements in Treatment

The Global Angina Market is witnessing a surge in innovative treatment options, including novel pharmacological therapies and minimally invasive procedures. These advancements are likely to enhance the efficacy of angina management, providing patients with more effective solutions.

Growing Awareness of Heart Health

There is an increasing emphasis on heart health education, which appears to be influencing patient behavior and encouraging proactive management of cardiovascular conditions. This trend may lead to higher demand for screening and preventive measures.

Demographic Shifts and Aging Population

The aging population is contributing to a rise in cardiovascular diseases, which could drive the demand for specialized angina treatments. This demographic trend suggests a need for healthcare systems to adapt to the unique needs of older patients.

Angina Market Market Drivers

Advancements in Medical Technology

Technological innovations in medical devices and treatment methodologies are transforming The Global Angina Industry. The introduction of minimally invasive procedures, such as percutaneous coronary interventions, has revolutionized the management of angina. These advancements not only enhance patient outcomes but also reduce recovery times, making treatments more appealing to patients and healthcare providers alike. Additionally, the development of advanced diagnostic tools, such as high-resolution imaging techniques, allows for earlier detection and more personalized treatment plans. As these technologies become more widely adopted, they are expected to drive market growth by improving the efficacy of angina management. The integration of telemedicine and digital health solutions further supports this trend, enabling remote monitoring and management of patients, which could lead to increased adherence to treatment protocols and better overall health outcomes in The Global Angina Industry.

Growing Focus on Preventive Healthcare

The shift towards preventive healthcare is significantly impacting The Global Angina Industry. As awareness of heart health increases, individuals are more inclined to seek preventive measures to mitigate the risk of developing angina and other cardiovascular conditions. This trend is reflected in the rising demand for screening programs, lifestyle modification initiatives, and educational campaigns aimed at promoting heart health. Healthcare providers are increasingly emphasizing the importance of early intervention and risk factor management, which could lead to a decrease in the incidence of angina. Consequently, this proactive approach may result in a more informed patient population that actively engages in their health, thereby driving the demand for preventive therapies and interventions within The Global Angina Industry.

Regulatory Support for Innovative Therapies

Regulatory bodies are playing a pivotal role in shaping The Global Angina Industry by providing support for the development and approval of innovative therapies. Streamlined approval processes for new drugs and treatment modalities encourage pharmaceutical companies to invest in research and development. This regulatory environment fosters innovation, leading to the introduction of novel therapies that can effectively address the needs of angina patients. Additionally, incentives for the development of orphan drugs and therapies targeting specific patient populations may further stimulate market growth. As regulatory frameworks evolve to support advancements in treatment options, The Global Angina Industry is likely to experience an influx of new products, enhancing the overall landscape of angina management.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is a primary driver for The Global Angina Industry. As lifestyle-related factors such as poor diet, lack of physical activity, and high stress levels contribute to heart conditions, the demand for effective angina treatments rises. According to health statistics, cardiovascular diseases account for a significant portion of global mortality, prompting healthcare systems to prioritize management strategies. This trend is likely to bolster the market for angina therapies, as patients seek interventions to alleviate symptoms and improve quality of life. Furthermore, the growing burden of these diseases necessitates innovative treatment options, thereby stimulating research and development in the pharmaceutical sector. Consequently, The Global Angina Industry is poised for growth as healthcare providers focus on addressing the needs of an increasingly affected population.

Increased Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a crucial factor influencing The Global Angina Industry. Governments and private entities are increasingly allocating resources to enhance healthcare facilities, particularly in regions with high rates of cardiovascular diseases. This investment often translates into improved access to diagnostic and treatment services for angina patients. Enhanced healthcare infrastructure facilitates the availability of advanced treatment options, which can lead to better patient outcomes and increased demand for angina therapies. Moreover, the establishment of specialized cardiac care centers is likely to provide comprehensive management for patients suffering from angina, further driving market growth. As healthcare systems evolve and expand, The Global Angina Industry stands to benefit from the increased accessibility and quality of care provided to patients.

Market Segment Insights

By Type: Angina Market Pectoris (Largest) vs. Unstable Angina Market (Fastest-Growing)

<p>In The Global Angina Market, angina pectoris holds the largest share, representing a significant portion of total cases. Unstable angina, while smaller in market share, is emerging as a critical focus due to its acute nature and potential for increased hospitalization and emergency intervention. Other types, including prinzmetal angina and miscellaneous cases, contribute to the market but do so at a lesser extent than the more prevalent forms of angina. Growth trends indicate that the population's aging demographics, along with rising levels of <a href="https://www.marketresearchfuture.com/reports/cardiovascular-diseases-market-6175">cardiovascular diseases</a>, drive the demand for effective management of angina conditions. The increased awareness of heart-related issues and advancements in medical treatment options further amplify the interest and investment in addressing unstable angina, which has been identified as a rapidly growing area in the market.</p>

<p>Angina Market Pectoris (Dominant) vs. Prinzmetal Angina Market (Emerging)</p>

<p>Angina Market pectoris is characterized by chest pain resulting from reduced blood flow to the heart, making it the dominant type in The Global Angina Market due to its prevalence and straightforward recognition. Meanwhile, prinzmetal angina is considered emerging as it presents a unique pattern of chest pain related to coronary artery spasm rather than physical exertion. The unique characteristics of prinzmetal angina&mdash;often occurring at rest and associated with specific triggers&mdash;make it both a critical area for research and a unique challenge for treatment. As clinicians increasingly seek to understand and address this type of angina, it may gain more prominence in the market, influencing therapeutic innovation and expanding patient management options.</p>

By Diagnosis: Imaging (Largest) vs. Blood Test (Fastest-Growing)

<p>In The Global Angina Market, the diagnosis segment is primarily driven by imaging, which holds the largest market share due to its effectiveness in visualizing anatomical structures and diagnosing conditions. Imaging techniques such as echocardiography and angiography are widely adopted for their precision and reliability, making them the preferred choice among healthcare professionals. Blood tests, though currently smaller in market share, are rapidly gaining traction as advancements in biomarkers and technologies emerge, enhancing their diagnostic capabilities. The growth trends in the diagnosis segment indicate a broader shift towards non-invasive and efficient diagnostic methods. The rise in healthcare awareness, combined with an increase in case prevalence, is driving the adoption of innovative diagnostic technologies. Additionally, the growing emphasis on early detection and personalized treatment plans is propelling the adoption of blood tests, which are seen as complementary to traditional imaging methods. Overall, this segment is witnessing dynamic changes, with emerging technologies reshaping diagnostic protocols and practices.</p>

<p>Imaging (Dominant) vs. Stress Test (Emerging)</p>

<p>In the context of The Global Angina Market, imaging stands as a dominant diagnostic tool primarily due to its ability to provide detailed anatomical views of cardiac structures. This method includes techniques like echocardiograms and coronary angiography, which are integral in evaluating blood flow and detecting blockages. The accuracy and reliability of imaging have solidified its place in standard clinical protocols, addressing a wide array of cardiac conditions effectively. On the other hand, stress tests, categorized as emerging diagnostic solutions, are gaining popularity for their role in assessing cardiac function under physical exertion. Although currently less prevalent than imaging, they are increasingly recognized for their value in comprehensive cardiovascular assessments, especially in scenarios where patients present atypical symptoms or need to gauge the efficacy of ongoing treatments.</p>

By Treatment: Medications (Largest) vs. Angioplasty and Stenting (Fastest-Growing)

<p>In The Global Angina Market, the treatment segment exhibits a diverse distribution, with medications holding the largest share. This includes a broad category of pharmaceuticals that aid in managing angina symptoms effectively. Following medications, angioplasty and stenting have emerged as a rapidly growing segment, reflecting advances in minimally invasive procedures that enhance patient outcomes. Other segments such as lifestyle changes, coronary bypass surgery, and others contribute to the market, although their shares are comparatively smaller. The growth trends within this segment are primarily driven by increasing prevalence of cardiovascular diseases and a growing geriatric population. Innovations in drug formulations and techniques in interventional cardiology, like angioplasty and stenting, are also contributing factors. The shift towards preventive measures, including lifestyle changes, is further catalyzing market expansion, catering to the rising awareness of heart health and the demand for holistic treatment approaches.</p>

<p>Medications: Pharmacological Treatments (Dominant) vs. Angioplasty: Invasive Procedures (Emerging)</p>

<p>Medications are the cornerstone of treatment in The Global Angina Market, encompassing a range of pharmacological therapies aimed at alleviating chest pain and improving quality of life. These treatments include beta-blockers, nitrates, and calcium channel blockers, which have established efficacy in managing angina symptoms. Their dominance is attributed to their widespread availability and the established protocols governing their use in clinical settings. On the other hand, angioplasty and stenting are emerging as crucial alternatives in specific cases, providing a less invasive option that yields quick recovery and relief from symptoms. This segment is witnessing accelerated growth due to technological advancements and increasing patient preference for quicker interventions. Together, they represent a significant dichotomy in treatment approaches, with medications remaining the standard and angioplasty offering an innovative option.</p>

By End-User: Hospitals and Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing)

<p>In The Global Angina Market, the primary distribution of market share among end-users reveals hospitals and clinics as the dominant segment, capturing a significant proportion of the market. This is due to their extensive resources, capability to provide comprehensive treatment options, and a well-established patient base. Following them, diagnostic centers are also emerging strongly as they play a crucial role in the early detection and timely diagnosis of angina, contributing to an evolving market landscape.</p>

<p>Hospitals and Clinics: Dominant vs. Diagnostic Centers: Emerging</p>

<p>Hospitals and clinics serve as the cornerstone of the healthcare infrastructure, offering specialized services for angina patients, including invasive procedures and ongoing management. Their established reputation and comprehensive care facilities ensure they remain the dominant end-user segment. Meanwhile, diagnostic centers, noted for their fast growth, provide essential diagnostic services that enhance early detection rates of angina, thereby increasing patient turnaround time for treatment. While hospitals focus on advanced treatment, diagnostic centers are pivotal in patient management pathways, showcasing complementary roles that enhance the overall healthcare delivery system.</p>

Get more detailed insights about Angina Market Research Report - Forecast to 2035

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for angina treatments, holding approximately 45% of the global market share. The region benefits from advanced healthcare infrastructure, high disposable incomes, and a growing aging population, which drives demand for effective angina therapies. Regulatory support from agencies like the FDA further catalyzes market growth by expediting the approval of new drugs and therapies. The United States and Canada are the leading countries in this region, with major pharmaceutical companies like Pfizer, Merck & Co., and Bristol-Myers Squibb actively involved in developing innovative treatments. The competitive landscape is characterized by a mix of established players and emerging biotech firms, all striving to capture market share through research and development initiatives.

Europe : Regulatory Framework Strength

Europe is the second-largest market for angina treatments, accounting for about 30% of the global market share. The region's growth is driven by increasing healthcare expenditure, a rise in cardiovascular diseases, and supportive regulatory frameworks. The European Medicines Agency (EMA) plays a crucial role in facilitating the approval of new therapies, which enhances market accessibility and patient care. Leading countries in Europe include Germany, France, and the United Kingdom, where key players like AstraZeneca and Novartis are heavily invested in research and development. The competitive landscape is robust, with numerous collaborations between pharmaceutical companies and research institutions aimed at advancing treatment options for angina patients.

Asia-Pacific : Emerging Market Potential

Asia-Pacific is witnessing rapid growth in the angina market, holding approximately 20% of the global market share. Factors such as increasing urbanization, rising disposable incomes, and a growing prevalence of lifestyle-related diseases are driving demand for angina treatments. Governments in the region are also implementing healthcare reforms to improve access to medical services, which is expected to further boost market growth. Countries like China and India are at the forefront of this growth, with a significant presence of both local and international pharmaceutical companies. The competitive landscape is evolving, with key players like Sanofi and Bayer expanding their operations to cater to the increasing demand for effective angina therapies in these emerging markets.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region represents a smaller segment of The Global Angina Market, accounting for about 5% of the total market share. However, the region is characterized by untapped opportunities due to increasing healthcare investments and a rising burden of cardiovascular diseases. Governments are focusing on improving healthcare infrastructure, which is expected to drive demand for angina treatments in the coming years. Leading countries in this region include South Africa and the UAE, where there is a growing presence of international pharmaceutical companies. The competitive landscape is gradually evolving, with key players like Amgen and GlaxoSmithKline looking to expand their footprint in this region, capitalizing on the increasing healthcare needs of the population.

Key Companies in the Angina Market market include

Industry Developments

Future Outlook

Angina Market Future Outlook

<p>The Global Angina Market is projected to grow at a 5.52% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in treatment options, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of telehealth platforms for remote patient monitoring.</p>
  • <p>Investment in AI-driven diagnostic tools for early angina detection.</p>
  • <p>Expansion of personalized medicine approaches targeting angina management.</p>

<p>By 2035, The Global Angina Market is expected to achieve substantial growth, reflecting evolving healthcare dynamics.</p>

Market Segmentation

Angina Market Type Outlook

  • angina pectoris
  • unstable angina
  • prinzmetal angina
  • others

Angina Market End-User Outlook

  • hospitals and clinics
  • diagnostic centers
  • academic institutes
  • others

Angina Market Diagnosis Outlook

  • imaging
  • blood test
  • stress test
  • others

Angina Market Treatment Outlook

  • lifestyle changes
  • medications
  • angioplasty and stenting
  • coronary bypass surgery
  • others

Report Scope

MARKET SIZE 2024 0.5487(USD Billion)
MARKET SIZE 2025 0.579(USD Billion)
MARKET SIZE 2035 0.9909(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.52% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Market analysis in progress
Segments Covered Market segmentation analysis in progress
Key Market Opportunities Advancements in telemedicine and digital health solutions enhance patient management in The Global Angina.
Key Market Dynamics Rising prevalence of cardiovascular diseases drives demand for innovative therapies and treatment options in the angina market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of The Global Angina as of 2024?

The Global Angina was valued at 0.5487 USD Billion in 2024.

What is the projected market valuation for The Global Angina in 2035?

The market is projected to reach a valuation of 0.9909 USD Billion by 2035.

What is the expected CAGR for The Global Angina during the forecast period 2025 - 2035?

The expected CAGR for The Global Angina during the forecast period 2025 - 2035 is 5.52%.

Which companies are considered key players in The Global Angina?

Key players in the market include AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer, Sanofi, Merck &amp; Co., GlaxoSmithKline, Amgen, and Bayer.

What are the main segments of The Global Angina?

The main segments of the market include Type, Diagnosis, Treatment, and End-User.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Introduction
    3. Primary Research
    4. Secondary research
    5. Market Size Estimation
    6. Drivers
    7. Restrains
    8. Opportunities
    9. Challenges
    10. Macroeconomic Indicators
    11. Technology Trends & Assessment
    12. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    13. Value Chain Analysis
    14. Investment Feasibility Analysis
    15. Pricing Analysis
  2. Chapter 6. Global Angina Market, by Type
    1. Introduction
    2. Angina Pectoris
    3. Market Estimates & Forecast, 2020–2027
    4. Unstable Angina
    5. Market Estimates & Forecast, 2020–2027
    6. Prinzmetal Angina
    7. Market Estimates & Forecast, 2020–2027
    8. Others
  3. Chapter 7. Global Angina Market, by Diagnosis
    1. Introduction
    2. Imaging
      1. Electrocardiogram
      2. Chest X-ray
      3. Cardiac Computerized Tomography Scan
      4. Cardiac MRI
      5. Others
    3. Market Estimates & Forecast, 2020–2027
    4. Blood Tests
      1. Cholesterol Test
      2. Low-Density Lipoprotein Test
      3. Triglycerides Test
      4. Others
    5. Market Estimates & Forecast, 2020–2027
    6. Stress Test
    7. Market Estimates & Forecast, 2020–2027
    8. Others
  4. Chapter 8. Global Angina Market, by Treatment
    1. Introduction
    2. Lifestyle Changes
    3. Market Estimates & Forecast, 2020–2027
    4. Medications
      1. Aspirin
      2. Clot-Preventing Drugs
      3. Statins
      4. Ranolazine
      5. Others
    5. Market Estimates & Forecast, 2020–2027
    6. Market Estimates & Forecast, 2020–2027
    7. Angioplasty and Stenting
    8. Market Estimates & Forecast, 2020–2027
    9. Coronary Bypass Surgery
    10. Market Estimates & Forecast, 2020–2027
    11. Others
  5. Chapter 9. Global Angina Market, by End-User
    1. Introduction
    2. Hospital & Clinics
    3. Market Estimates & Forecast, 2020–2027
    4. Diagnostic Centers
    5. Market Estimates & Forecast, 2020–2027
    6. Academic Institutes
    7. Market Estimates & Forecast, 2020–2027
    8. Others
  6. Chapter 10. Global Angina Market, by Region
    1. Introduction
    2. America
      1. North America
      2. South America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. Republic of Korea
      6. Rest of Asia Pacific
    5. The Middle East & Africa
      1. United Arab Emirates
      2. Saudi Arabia
      3. Oman
      4. Kuwait
      5. Qatar
      6. Rest of the Middle East & Africa
    6. Chapter 11. Company Landscape
    7. Introduction
    8. Market Share Analysis
    9. Key Development & Strategies
      1. Key Developments
    10. Chapter 12 Company Profiles
    11. Anthera
      1. Company Overview
      2. Type Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    12. Taxus Cardium
      1. Company Overview
      2. Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    13. Astellas Pharma
      1. Company Overview
      2. Type Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    14. Sanofi
      1. Company Overview
      2. Type/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    15. Bayer AG
      1. Company Overview
      2. Type Overview
      3. Financial overview
      4. Key Developments
      5. SWOT Analysis
    16. Merck & Co., Inc.
      1. Company Overview
      2. Type Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    17. Torrent Pharmaceuticals
      1. Overview
      2. Type Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    18. Huya Bioscience International
      1. Overview
      2. Type Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    19. Viromed Co. Ltd.
      1. Overview
      2. Type Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    20. Baxter
      1. Overview
      2. Type Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    21. Others
    22. Chapter 13 MRFR Conclusion
    23. Key Findings
      1. From CEO’s View Point
      2. Unmet Needs of the Market
    24. Key Companies to Watch
    25. Prediction of Angina Market
    26. Chapter 14 Appendix
  7. LIST OF TABLES
  8. Angina Industry Synopsis, 2020–2027
  9. Global Angina Market Estimates & Forecast, 2020–2027, (USD Million)
  10. Global Angina Market, by Region, 2020–2027, (USD Million)
  11. Global Angina Market, by Type, 2020–2027, (USD Million)
  12. Global Angina Market, by Diagnosis, 2020–2027, (USD Million)
  13. Global Angina Market, by Treatment, 2020–2027, (USD Million)
  14. Global Angina Market, by End-User, 2020–2027, (USD Million
  15. North America Angina Market, by Type, 2020–2027, (USD Million)
  16. North America Angina, by Diagnosis, 2020–2027, (USD Million)
  17. North America Angina, by Treatment, 2020–2027, (USD Million)
  18. North America Angina, by End-User, 2020–2027, (USD Million)
  19. U.S. Angina Market, by Type, 2020–2027, (USD Million)
  20. U.S. Angina Market, by Diagnosis, 2020–2027, (USD Million)
  21. U.S. Angina Market, by Treatment, 2020–2027, (USD Million)
  22. U.S. Angina Market, by End-User, 2020–2027, (USD Million)
  23. Canada Angina Market, by Type, 2020–2027, (USD Million)
  24. Canada Angina Market, by Diagnosis, 2020–2027, (USD Million)
  25. Canada Angina Market, by Treatment, 2020–2027, (USD Million)
  26. Canada Angina Market, by End-User, 2020–2027, (USD Million)
  27. South America Angina Market, by Type, 2020–2027, (USD Million)
  28. South America Angina Market, by Diagnosis, 2020–2027, (USD Million)
  29. South America Angina Market, by Treatment, 2020–2027, (USD Million)
  30. South America Angina Market, by End-User, 2020–2027, (USD Million)
  31. Europe Angina Market, by Type, 2020–2027, (USD Million)
  32. Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
  33. Europe Angina Market, by Treatment, 2020–2027, (USD Million)
  34. Europe Angina Market, by End-User, 2020–2027, (USD Million)
  35. Western Europe Angina Market, by Type, 2020–2027, (USD Million)
  36. Western Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
  37. Western Europe Angina Market, by Treatment, 2020–2027, (USD Million)
  38. Western Europe Angina Market, by End-User, 2020–2027, (USD Million)
  39. Eastern Europe Angina Market, by Type, 2020–2027, (USD Million)
  40. Eastern Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
  41. Eastern Europe Angina Market, by Treatment, 2020–2027, (USD Million)
  42. Eastern Europe Angina Market, by End-User, 2020–2027, (USD Million)
  43. Asia Pacific Angina Market, by Type, 2020–2027, (USD Million)
  44. Asia Pacific Angina Market, by Diagnosis, 2020–2027, (USD Million)
  45. Asia Pacific Angina Market, by Treatment, 2020–2027, (USD Million)
  46. Asia Pacific Angina Market, by End-User, 2020–2027, (USD Million)
  47. The Middle East & Africa Angina Market, by Type, 2020–2027, (USD Million)
  48. The Middle East & Africa Angina Market, by Diagnosis, 2020–2027, (USD Million)
  49. The Middle East & Africa Angina Market, by Treatment, 2020–2027, (USD Million)
  50. The Middle East & Africa Angina Market, by End-User, 2020–2027, (USD Million)
  51. LIST OF FIGURES
  52. Research Process
  53. Segmentation for Global Angina Market
  54. Market Dynamics for Global Angina Market
  55. Global Angina Market Share, by Type 2020
  56. Global Angina Market Share, by Diagnosis 2020
  57. Global Angina Market Share, by Treatment, 2020
  58. Global Angina Market Share, by End-User, 2020
  59. Global Angina Market Share, by Region, 2020
  60. North America Angina Market Share, by Country, 2020
  61. Europe Angina Market Share, by Country, 2020
  62. Asia Pacific Angina Market Share, by Country, 2020
  63. The Middle East & Africa Angina Market Share, by Country, 2020
  64. Global Angina Market: Company Share Analysis, 2020 (%)
  65. Anthera: Key Financials
  66. Anthera: Segmental Revenue
  67. Anthera: Geographical Revenue
  68. Taxus Cardium: Key Financials
  69. Taxus Cardium: Segmental Revenue
  70. Taxus Cardium: Geographical Revenue
  71. Astellas Pharma: Key Financials
  72. Astellas Pharma: Segmental Revenue
  73. Astellas Pharma: Geographical Revenue
  74. Sanofi: Key Financials
  75. Sanofi: Segmental Revenue
  76. Sanofi: Geographical Revenue
  77. Bayer AG: Key Financials
  78. Bayer AG: Segmental Revenue
  79. Bayer AG: Geographical Revenue
  80. Merck & Co., Inc.: Key Financials
  81. Merck & Co., Inc.: Segmental Revenue
  82. Merck & Co., Inc.: Geographical Revenue
  83. Torrent Pharmaceuticals Limited: Key Financials
  84. Torrent Pharmaceuticals Limited: Segmental Revenue
  85. Torrent Pharmaceuticals Limited: Geographical Revenue
  86. Huya Bioscience International: Key Financials
  87. Huya Bioscience International: Segmental Revenue
  88. Huya Bioscience International: Geographical Revenue
  89. Viromed Co. Ltd.: Key Financials
  90. Viromed Co. Ltd.: Segmental Revenue
  91. Viromed Co. Ltd.: Geographical Revenue
  92. Baxter: Key Financials
  93. Baxter: Segmental Revenue
  94. Baxter: Geographical Revenue

Angina Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓